Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)
Clinical trial NCT00827138 · COMPLETED
Trial details
- NCT number
- NCT00827138
- Sponsor
- Deciphera Pharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2013-01-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.